Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
CALL
Alnylam Pharmaceuticals
ALNY
$30.6B
| $2.16M | ﹤0.01% |
29,800
-55,300
| -65% | -$4.24M |
|
4202
BOK Financial
BOKF
$8.88B
| $2.16M | ﹤0.01% |
28,649
+21,648
| +309% | +$1.76M |
|
4203
CALL
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.12B
| $2.16M | ﹤0.01% |
8,680
+3,110
| +56% | +$685K |
|
4204
Vident International Equity Strategy
VIDI
$450M
| $2.16M | ﹤0.01% |
89,405
-6,431
| -7% | -$155K |
|
4205
CALL
Cameco
CCJ
$42.6B
| $2.16M | ﹤0.01% |
201,100
+116,500
| +138% | +$1.25M |
|
4206
PUT
Ligand Pharmaceuticals
LGND
$5.87B
| $2.16M | ﹤0.01% |
30,297
-54,983
| -64% | -$4.05M |
|
4207
CALL
Ares Capital
ARCC
$14.3B
| $2.15M | ﹤0.01% |
120,100
-162,500
| -58% | -$2.88M |
|
4208
AutoZone
AZO
$49.4B
| $2.15M | ﹤0.01% |
1,960
-21,863
| -92% | -$23M |
|
4209
Carlyle Group
CG
$17.6B
| $2.15M | ﹤0.01% |
95,185
+35,359
| +59% | +$728K |
|
4210
iShares Global Financials ETF
IXG
$702M
| $2.15M | ﹤0.01% |
33,570
-31,567
| -48% | -$2.01M |
|
4211
CALL
Fidelity National Financial
FNF
$13.3B
| $2.15M | ﹤0.01% |
55,432
+13,312
| +32% | +$502K |
|
4212
NovoCure
NVCR
$1.97B
| $2.15M | ﹤0.01% |
33,953
-36,238
| -52% | -$1.84M |
|
4213
CALL
CrowdStrike
CRWD
$221B
| $2.14M | ﹤0.01% |
+125,600
| New | +$2.14M |
|
4214
Lindsay Corp
LNN
$1.17B
| $2.14M | ﹤0.01% |
26,075
-2,012
| -7% | -$168K |
|
|
EXTN
4215
DELISTED
Exterran Corporation
EXTN
| $2.14M | ﹤0.01% |
150,786
+6,616
| +5% | +$97K |
|
4216
PUT
Tower Semiconductor
TSEM
$30B
| $2.14M | ﹤0.01% |
135,900
+41,100
| +43% | +$685K |
|
|
NAV
4217
CALL
DELISTED
Navistar International
NAV
| $2.14M | ﹤0.01% |
62,200
-39,100
| -39% | -$1.3M |
|
|
IMMU
4218
PUT
DELISTED
Immunomedics Inc
IMMU
| $2.14M | ﹤0.01% |
154,400
-56,300
| -27% | -$847K |
|
4219
CALL
Levi Strauss
LEVI
$8.68B
| $2.14M | ﹤0.01% |
102,500
+86,800
| +553% | +$1.91M |
|
4220
Shutterstock
SSTK
$210M
| $2.14M | ﹤0.01% |
54,620
-2,204
| -4% | -$91.5K |
|
4221
CALL
Arrowhead Research
ARWR
$12.2B
| $2.14M | ﹤0.01% |
80,600
+21,800
| +37% | +$478K |
|
4222
Mueller Industries
MLI
$14.6B
| $2.14M | ﹤0.01% |
291,904
+35,108
| +14% | +$257K |
|
|
DISCK
4223
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $2.13M | ﹤0.01% |
75,000
-4,200
| -5% | -$114K |
|
4224
argenx
ARGX
$53.3B
| $2.13M | ﹤0.01% |
15,055
+6,712
| +80% | +$852K |
|
4225
Four Corners Property Trust
FCPT
$2.77B
| $2.13M | ﹤0.01% |
77,934
+58,406
| +299% | +$1.67M |
|
Similar funds
Citadel Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
- Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
- Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.